HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

NAPVSIPQ peptide

AL-108 is a nasal systemic formulation; AL-208 is an intravenous formulation; associated with glial proteins regulated by vasoactive intestinal peptide, are shown now to provide protective intervention in a model of fetal alcohol syndrome
Also Known As:
AL 108; AL 208; AL-108; AL-208; AL108 cpd; AL208 cpd; NAP peptide; davunetide
Networked: 25 relevant articles (6 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Gozes, Illana: 14 articles (07/2014 - 10/2009)
2. Morimoto, Bruce H: 4 articles (07/2014 - 01/2012)
3. Gold, Michael: 4 articles (07/2014 - 01/2012)
4. Stewart, Alistair J: 3 articles (07/2014 - 01/2012)
5. Giladi, Eliezer: 3 articles (08/2013 - 07/2010)
6. Bhargava, Kalpana: 2 articles (11/2014 - 06/2011)
7. Das, Mainak: 2 articles (11/2014 - 06/2011)
8. Williams, David R: 2 articles (07/2014 - 01/2012)
9. Hirman, Joe: 2 articles (07/2014 - 01/2013)
10. Lorenzl, Stefan: 2 articles (07/2014 - 01/2012)

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Alzheimer Disease (Alzheimer's Disease)
3. Tauopathies
4. Anoxia (Hypoxia)
5. Neurodegenerative Diseases (Neurodegenerative Disease)

Related Drugs and Biologics

1. Glutathione Disulfide (GSSG)
2. Kainic Acid (Kainate)
3. Choline (Choline Chloride)
4. N-acetylaspartate (N-acetyl aspartate)

Related Therapies and Procedures

1. Transplants (Transplant)
2. Therapeutics
3. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
4. Activities of Daily Living (ADL)